|
|
| | 2'-DEOXYURIDINE-2-13C,1,3-15N2 Basic information |
| Product Name: | 2'-DEOXYURIDINE-2-13C,1,3-15N2 | | Synonyms: | 2'-DEOXYURIDINE-2-13C,1,3-15N2;1-(2-Deoxy-b-D-erythro-pentofuranosyl)uracil-13C,15N2;2Deoxyuridine-13C,15N2;2'-Desoxyuridine-13C,15N2;Deoxyribose Uracil-13C,15N2;NSC 23615-13C,15N;2-DEOXYURIDINE-13C1,15N2;1-(2-Deoxy--D-erythro-pentofuranosyl)uracil-13C,15N2 | | CAS: | 369656-76-8 | | MF: | C9H12N2O5 | | MW: | 231.18 | | EINECS: | | | Product Categories: | Bases & Related Reagents;Carbohydrates & Derivatives;Heterocycles;Isotope Labeled Compounds;Nucleotides;Isotope Labelled Compounds | | Mol File: | 369656-76-8.mol |  |
| | 2'-DEOXYURIDINE-2-13C,1,3-15N2 Chemical Properties |
| Melting point | 159-163°C | | density | 1.534±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | storage temp. | -20°C Freezer | | solubility | DMSO (Slightly), Methanol (Slightly, Sonicated) | | form | Solid | | color | Off-White to Pale Yellow |
| | 2'-DEOXYURIDINE-2-13C,1,3-15N2 Usage And Synthesis |
| Chemical Properties | White Solid | | Uses | An uridine labelled derivative as therapeutic agent for treating allergy, cancer, infection and autoimmune disease. |
| | 2'-DEOXYURIDINE-2-13C,1,3-15N2 Preparation Products And Raw materials |
|